Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians

European Journal of Heart Failure

Volumn 7, Issue 4, 2005, Pages 604-611

  Schuchert, A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Adrenergic beta antagonists; Bisoprolol; Blood pressure; Chronic heart failure; Heart rate; NYHA class

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BRADYCARDIA; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGUS CARCINOMA; FATIGUE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOTENSION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SUDDEN DEATH; SYNCOPE; TITRIMETRY; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; BISOPROLOL; BLOOD PRESSURE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 19544394214     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.03.008     Document Type: Article

References (22)

1. Lloyd-Jones D.M., Larson M.G., Leip E.P., Beiser A., D'Agostino R.B., Kannel W.B., et al. Lifetime risk for developing congestive heart failure. The Framingham Heart Study. Circulation. 106:2002;3068-3072
2. Cleland J.G.F., Khand A., Clark A.L. The heart failure epidemic: exactly how big is it. Eur Heart J. 22:2001;623-626
3. Stewart S., MacIntyre K., MacLeod M.M.C., Bailey A.E.M., Capewell S., McMurray J.J.V. Trends in hospitalization for heart failure in Scotland, 1990-1996. Eur Heart J. 22:2001;209-217
4. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure: Part I. Circulation. 105:2002;2099-2106
5. Cleland JGF, Cohen-Solal A, Cosin Aguilar J, Dietz R, Eastaugh J, Follath F, et al., for the IMPROVEMENT of Heart Failure. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631-39
6. The Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology, Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe Part 2: treatment. Eur Heart J 2003; 24: 464-74
7. CIBIS Investigators. A randomized trial of ß-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study. Circulation. 90:1994;1765-1773
8. Baxter A.J., Spensley, Hidreth A., Karimova, O'Connell J.E., Gray C.S. Beta-blockers in older persons with heart failure; tolerability and impact on quality of life. Heart. 88:2002;611-614
9. CIBIS II Investigators and Committee. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial. Lancet. 353:1999;9-13
10. MERIT-HF Study Group. Effect of metoprolol cr/xl in chronic heart failure: metoprolol cr/xl randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 353:1999;2001-2007
11. Packer M, Coats AJS, Fowler M, Katus H, Krum H, Mohacsi P et al. for the carvedilol prospective randomized cumulative survival study group. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 2001; 344: 1651-8
12. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al. Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003; 362: 7-13
13. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560
14. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldmanmd A.M., Francis G.S., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation. 104:2001;2996-3007
15. Hobbs F.D.R., Jones M.I., Allan T.F., Wilson S., Tobias R. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J. 21:2000;1877-1887
16. Bellotti P, Badano LP, Acquarone N, Griffo R, Lo Pinto G, Maggioni AP et al. for the OSCUR investigators. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study. Eur Heart J 2001; 22: 596-604
17. Eichholz E.J., Bristow M.R. Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure. Am J Cardiol. 79:1997;794-798
18. McMurray J., Cohen-Solol A., Dietz R., Eichhorn E., Erhardt L., Hobbs R., et al. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail. 3:2001;495-502
19. Simon T, Mary-Krause M, Funck-Brentano C, Lechat Ph, Jaillon P, on behalf of CIBIS II Investigators. Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study (CIBIS II). Eur Heart J 2003; 24: 552-559
20. Lechat P, Hulot J-S, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, et al. on behalf of the CIBIS II Investigators. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS. Circulation. 2001; 103:1428-1433
21. Lechat P, Escolano S, Golmard JL, Lardoux H, Witchitz S, Hennemann JA, et al. on behalf of the CIBIS Investigators. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1997; 96: 2197-2205
22. CIBIS-II Investigators and Health Economics Group. Reduced costs with bisoprolol treatment for heart failure. Eur Heart J. 22:2001;1021-1031